Filtros : "IQ-QBQ" "Nova Zelândia" Removidos: "IFSC008" "República Checa" "Encontro de Administração da Informação - EnADI" "ODONTOLOGIA" "Animal Scientist" "Cozzolino, Silvia Maria Franciscato" Limpar

Filtros



Refine with date range


  • Source: Drug Combination Therapy. Unidade: IQ

    Subjects: MEDICAMENTO, TERAPIA COMBINADA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELLO, Renata Siqueira de et al. Complex diseases demand novel treatment strategies: understanding drug combination. Drug Combination Therapy, v. 4, n. 2, p. 1-12 art. 6, 2022Tradução . . Disponível em: https://doi.org/10.53388/DCT2022006. Acesso em: 03 jul. 2024.
    • APA

      Mello, R. S. de, Sampaio, V. F. A., Maciel, L. F., Sá, V. de, Glaser, T., Ulrich, H., & Lameu, C. (2022). Complex diseases demand novel treatment strategies: understanding drug combination. Drug Combination Therapy, 4( 2), 1-12 art. 6. doi:10.53388/DCT2022006
    • NLM

      Mello RS de, Sampaio VFA, Maciel LF, Sá V de, Glaser T, Ulrich H, Lameu C. Complex diseases demand novel treatment strategies: understanding drug combination [Internet]. Drug Combination Therapy. 2022 ; 4( 2): 1-12 art. 6.[citado 2024 jul. 03 ] Available from: https://doi.org/10.53388/DCT2022006
    • Vancouver

      Mello RS de, Sampaio VFA, Maciel LF, Sá V de, Glaser T, Ulrich H, Lameu C. Complex diseases demand novel treatment strategies: understanding drug combination [Internet]. Drug Combination Therapy. 2022 ; 4( 2): 1-12 art. 6.[citado 2024 jul. 03 ] Available from: https://doi.org/10.53388/DCT2022006
  • Source: International Journal of Nanomedicine. Unidades: IQSC, IQ

    Subjects: LIPOSSOMOS, CARCINOMA HEPATOCELULAR, ANTINEOPLÁSICOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LUNA, Arthur Cássio de Lima et al. Potential antitumor activity of novel DODAC/PHO-S liposomes. International Journal of Nanomedicine, v. 11, p. 1577–1591, 2016Tradução . . Disponível em: https://doi.org/10.2147/IJN.S90850. Acesso em: 03 jul. 2024.
    • APA

      Luna, A. C. de L., Saraiva, G. K. V., Ribeiro Filho, O. M., Chierice, G. O., Claro Neto, S., Cuccovia, I. M., & Maria, D. A. (2016). Potential antitumor activity of novel DODAC/PHO-S liposomes. International Journal of Nanomedicine, 11, 1577–1591. doi:10.2147/IJN.S90850
    • NLM

      Luna AC de L, Saraiva GKV, Ribeiro Filho OM, Chierice GO, Claro Neto S, Cuccovia IM, Maria DA. Potential antitumor activity of novel DODAC/PHO-S liposomes [Internet]. International Journal of Nanomedicine. 2016 ; 11 1577–1591.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2147/IJN.S90850
    • Vancouver

      Luna AC de L, Saraiva GKV, Ribeiro Filho OM, Chierice GO, Claro Neto S, Cuccovia IM, Maria DA. Potential antitumor activity of novel DODAC/PHO-S liposomes [Internet]. International Journal of Nanomedicine. 2016 ; 11 1577–1591.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2147/IJN.S90850
  • Source: Oncotarget. Unidade: IQ

    Subjects: METÁSTASE NEOPLÁSICA, NEOPLASIAS MAMÁRIAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CERQUEIRA, Otto Luiz Dutra et al. CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis. Oncotarget, v. 6, n. 11, p. 9397-9408 : + Materials supplementary ( S1-S4), 2015Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.3351. Acesso em: 03 jul. 2024.
    • APA

      Cerqueira, O. L. D., Truesdell, P., Baldassarre, T., Vilella Arias, S. A., Watt, K., Meens, J., et al. (2015). CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis. Oncotarget, 6( 11), 9397-9408 : + Materials supplementary ( S1-S4). doi:10.18632/oncotarget.3351
    • NLM

      Cerqueira OLD, Truesdell P, Baldassarre T, Vilella Arias SA, Watt K, Meens J, Chander H, Osório CAB de T, Soares FA, Reis EM, Craig AWB. CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis [Internet]. Oncotarget. 2015 ; 6( 11): 9397-9408 : + Materials supplementary ( S1-S4).[citado 2024 jul. 03 ] Available from: https://doi.org/10.18632/oncotarget.3351
    • Vancouver

      Cerqueira OLD, Truesdell P, Baldassarre T, Vilella Arias SA, Watt K, Meens J, Chander H, Osório CAB de T, Soares FA, Reis EM, Craig AWB. CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis [Internet]. Oncotarget. 2015 ; 6( 11): 9397-9408 : + Materials supplementary ( S1-S4).[citado 2024 jul. 03 ] Available from: https://doi.org/10.18632/oncotarget.3351
  • Source: International Journal of Nanomedicine. Unidade: IQ

    Subjects: PEPTÍDEOS, BIOQUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RAGIOTO, Danielle Aparecida Midori Tominaga e CARRASCO, Letícia Dias de Melo e CARMONA-RIBEIRO, Ana Maria. Novel gramicidin formulations in cationic lipid as broad spectrum microbicidal agents. International Journal of Nanomedicine, v. 9, n. 1, p. 3183-3192, 2014Tradução . . Disponível em: https://doi.org/10.2147/IJN.S65289. Acesso em: 03 jul. 2024.
    • APA

      Ragioto, D. A. M. T., Carrasco, L. D. de M., & Carmona-Ribeiro, A. M. (2014). Novel gramicidin formulations in cationic lipid as broad spectrum microbicidal agents. International Journal of Nanomedicine, 9( 1), 3183-3192. doi:10.2147/IJN.S65289
    • NLM

      Ragioto DAMT, Carrasco LD de M, Carmona-Ribeiro AM. Novel gramicidin formulations in cationic lipid as broad spectrum microbicidal agents [Internet]. International Journal of Nanomedicine. 2014 ; 9( 1): 3183-3192.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2147/IJN.S65289
    • Vancouver

      Ragioto DAMT, Carrasco LD de M, Carmona-Ribeiro AM. Novel gramicidin formulations in cationic lipid as broad spectrum microbicidal agents [Internet]. International Journal of Nanomedicine. 2014 ; 9( 1): 3183-3192.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2147/IJN.S65289
  • Source: International Journal of Nanomedicine. Unidade: IQ

    Subjects: NANOPARTÍCULAS, ANTÍGENOS, ADJUVANTES IMUNOLÓGICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARMONA-RIBEIRO, Ana Maria. Biomimetic nanoparticles: preparation, characterization and biomedical applications. International Journal of Nanomedicine, v. 5, p. 249-259, 2010Tradução . . Disponível em: https://doi.org/10.2147/ijn.s9035. Acesso em: 03 jul. 2024.
    • APA

      Carmona-Ribeiro, A. M. (2010). Biomimetic nanoparticles: preparation, characterization and biomedical applications. International Journal of Nanomedicine, 5, 249-259. doi:10.2147/ijn.s9035
    • NLM

      Carmona-Ribeiro AM. Biomimetic nanoparticles: preparation, characterization and biomedical applications [Internet]. International Journal of Nanomedicine. 2010 ; 5 249-259.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2147/ijn.s9035
    • Vancouver

      Carmona-Ribeiro AM. Biomimetic nanoparticles: preparation, characterization and biomedical applications [Internet]. International Journal of Nanomedicine. 2010 ; 5 249-259.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2147/ijn.s9035
  • Source: Drug Target Insights. Unidade: IQ

    Subjects: DNA, ÁCIDOS NUCLEICOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RESENDE, Rodrigo Ribeiro et al. Delivery systems for in vivo use of nucleic acid drugs. Drug Target Insights, n. 2, p. 183-196, 2007Tradução . . Acesso em: 03 jul. 2024.
    • APA

      Resende, R. R., Torres, H. A. M., Yuahasi, K. K., Majumder, P., & Ulrich, H. (2007). Delivery systems for in vivo use of nucleic acid drugs. Drug Target Insights, ( 2), 183-196.
    • NLM

      Resende RR, Torres HAM, Yuahasi KK, Majumder P, Ulrich H. Delivery systems for in vivo use of nucleic acid drugs. Drug Target Insights. 2007 ;( 2): 183-196.[citado 2024 jul. 03 ]
    • Vancouver

      Resende RR, Torres HAM, Yuahasi KK, Majumder P, Ulrich H. Delivery systems for in vivo use of nucleic acid drugs. Drug Target Insights. 2007 ;( 2): 183-196.[citado 2024 jul. 03 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024